RESUMEN
BACKGROUND: The hypereosinophilic syndrome (HES) is a group of rare blood disorders characterized by persistent eosinophilia and damage to multiple organs. HES can be either primary, secondary or idiopathic. Secondary HES are commonly caused by parasitic infections, allergic reactions or cancer. We described a pediatric case of HES associated with liver damage and multiple thrombi. A 12-year-old boy with eosinophilia was complicated with severe thrombocytopenia, liver damage, portal vein, splenic vein, and superior mesenteric vein thromboses. The thrombi recanalized after treatment with methylprednisolone succinate and low molecular weight heparin. No side effects appeared after 1-month. CONCLUSIONS: Corticosteroids should be used at an early stage of HES to prevent further damage to vital organs. Anticoagulants should be recommended only in cases with thrombosis which should be actively screened as a part of evaluation of end organ damage.
Asunto(s)
Síndrome Hipereosinofílico , Hepatopatías , Trombosis , Masculino , Humanos , Niño , Vena Porta/diagnóstico por imagen , Vena Esplénica/diagnóstico por imagen , Venas Mesentéricas/diagnóstico por imagen , Trombosis/etiología , Síndrome Hipereosinofílico/complicaciones , Síndrome Hipereosinofílico/diagnóstico , Síndrome Hipereosinofílico/tratamiento farmacológicoRESUMEN
BACKGROUND: Congenital nephrogenic diabetes insipidus (CNDI) is a rare hereditary disorder. It is associated with mutations in the arginine vasopressin receptor 2 (AVPR2) gene and aquaporin 2 (AQP2) gene, and approximately 270 different mutation sites have been reported for AVPR2. Therefore, new mutations and new manifestations are crucial to complement the clinical deficiencies in the diagnosis of this disease. We report a case of a novel AVPR2 gene mutation locus and a new clinical mani-festation. CASE SUMMARY: We describe the case of a 48-d-old boy who presented with recurrent fever and diarrhea 5 d after birth. Laboratory tests showed electrolyte disturbances and low urine specific gravity, and imaging tests showed no abnormalities. Genetic testing revealed a novel X-linked recessive missense mutation, c.283 (exon 2) C>T (p.P95S). This mutation results in the substitution of a proline residue with a serine residue in the AVPR2 protein sequence. The diagnosis of CNDI was confirmed based on the AVPR2 gene mutation. The treatment strategy for this patient was divided into two stages, including physical cooling supplemented with appropriate amounts of water in the early stage and oral hydrochlorothia-zide (1-2 mg/kg) after a clear diagnosis. After follow-up of one and a half years, the patient gradually improved. CONCLUSION: AVPR2 gene mutations in new loci and new clinical symptoms help clinicians understand this disease and shorten the diagnosis cycle.
RESUMEN
BACKGROUND: MKI67 plays a vital role in the tumour microenvironment (TME) and congenital immunity. The present work focuses on exploring the prognosis prediction performance of MKI67 and its associations with T cell activity and immune infiltration within numerous cancers, especially hepatocellular liver carcinoma (LIHC). METHODS: Oncomine, GEPIA2, and HPA were adopted to analyse MKI67 levels in different types of cancers. The prognostic prediction performance of MKI67 was evaluated through the TCGA portal, GEPIA2, LOGpc, and Kaplan-Meier Plotter databases. The associations of MKI67 with related gene marker sets and immune infiltration were inspected through TISIDB, GEPIA2, and TIMER. We chose MKI67 to analyse biological processes (BPs) and KEGG pathways related to the coexpressed genes. Furthermore, the gene-miRNA interaction network for MKI67 in liver cancer was also examined based on the miRWalk database. RESULTS: MKI67 expression decreased in many cancers related to the dismal prognostic outcome of LIHC. We found that MKI67 significantly affected the prognosis of LIHC in terms of histology and grade. Increased MKI67 levels were directly proportional to the increased immune infiltration degrees of numerous immune cells and functional T cells, such as exhausted T cells. In addition, several critical genes related to exhausted T cells, including TIM-3, TIGIT, PD-1, LAG3, and CXCL13, were strongly related to MKI67. Further analyses showed that MKI67 was associated with adaptive immunity, cell adhesion molecules (CAMs), and chemokine/immune response signal transduction pathways. CONCLUSION: MKI67 acts as a prognostic prediction biomarker in several cancers, particularly LIHC. Upregulation of MKI67 elevates the degree of immune infiltration of many immune cell subtypes, including functional T cells, CD4+ T cells, and CD8+ T cells. Furthermore, MKI67 shows a close correlation with T cell exhaustion, which plays a vital role in promoting T cell exhaustion within LIHC. Detection of the MKI67 level contributes to prognosis prediction and MKI67 modulation within exhausted T cells, thus providing a new method to optimize the efficacy of anti-LIHC immunotherapy.
Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Biomarcadores de Tumor/genética , Linfocitos T CD8-positivos , Humanos , Pronóstico , Microambiente TumoralRESUMEN
INTRODUCTION: The aim of this study was to evaluate the efficacy and safety of azithromycin (AZI) combined with glucocorticoid (GC) in the treatment of children with refractory Mycoplasma pneumoniae. METHODS: Computer search for PubMed, EMbase, Cochrane Library, China Biomedical Literature Database (CBMdisc), China Knowledge Network (CNKI), Wanfang, VIP (VIP), and a randomized controlled trial (RCT) of AZI combined with GC in the treatment of children with refractory Mycoplasma pneumoniae pneumonia test (RCT), the search time limit is built until March 20, 2019. Two researchers independently performed literature screening, data extraction, and literature risk bias, and meta-analysis was performed using RevMan 5.3 software. RESULTS: A total of 12 RCTs were included, including 1130 patients. Meta-analysis showed that AZI combined with GC therapy significantly improved the total effective rate of the disease compared with the conventional treatment group (odds ratio [OR]â=â6.37; 95% confidence interval [CI] 4.03, 10.07; Pâ<â.00001; Iâ=â0%), effectively shortened the antipyretic time (SMDâ=â-2.29; 95% CI -2.70, -1.88; Pâ<â.0001); promoted lung inflammation absorption (SMDâ=â-1.89; 95% CI -2.38, -1.40; Pâ<â.0001), reduced cough time (SMDâ=â-2.39; 95% CI -2.80, -1.99; Pâ<â.0001); shortened hospital stay (SMDâ=â-2.19; 95% CI -3.21, -1.17; Pâ<â.0001); improved imaging findings (ORâ=â5.38; 95% CI 1.09, 26.51, Pâ=â.04); reduced inflammation index (SMDâ=â-3.15; 95% CI -4.93, -1.36; Pâ=â.004); improved immune function (SMDâ=â1.29; 95% CI -0.02, 2.60; Pâ<â.0001); had no significant adverse reactions (ORâ=â1.18; 95% CI 0.71, 1.98; Pâ=â.53). CONCLUSIONS: According to the current limited research evidence, the addition of GCs to the conventional treatment of refractory Mycoplasma pneumoniae in children can improve the clinical efficacy to a certain extent, and the safety is better. However, due to the quality and quantity of the included literature, the conclusions of this study need to be confirmed by more high-quality studies.
Asunto(s)
Antibacterianos/uso terapéutico , Azitromicina/uso terapéutico , Glucocorticoides/uso terapéutico , Mycoplasma pneumoniae , Neumonía por Mycoplasma/tratamiento farmacológico , Antibacterianos/efectos adversos , Azitromicina/efectos adversos , Niño , Tos/tratamiento farmacológico , Tos/microbiología , Quimioterapia Combinada , Fiebre/tratamiento farmacológico , Fiebre/microbiología , Glucocorticoides/efectos adversos , Humanos , Tiempo de Internación , Neumonía por Mycoplasma/complicaciones , Neumonía por Mycoplasma/diagnóstico por imagenRESUMEN
Asymmetric annulation of allenes with electron-deficient olefins and imines is one of the most important reactions for the synthesis of optically active carbo- and heterocycles, which are useful building blocks for the synthesis of natural products and medicinally important substances. The use of chiral phosphines as enantioselective catalysts can be envisaged for such cyclizations. This article focuses on the important developments concerning asymmetric annulations of allenes with unsaturated partners in the recent decades and on the perspectives that these new developments offer.